Somatostatin as a Regulator of First-Trimester Human Trophoblast Functions

Placenta

Volumn 29, Issue 8, 2008, Pages 660-670

  Biondi, C ^a   Ferretti, M E ^a   Lunghi, L ^a   Medici, S ^a   Cervellati, F ^a   Abelli, L ^a   Bertoni, F ^a   Adinolfi, E ^a   Vesce, F ^a   Bartolini, G ^b   Papi, A ^b   D'Andrea, S ^c   Berton, S ^c   Baldassarre, G ^c  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

Cell proliferation; Cyclic AMP; Migration; Phospholipase A2; Somatostatin; Trophoblast derived cell lines

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; ARACHIDONIC ACID; BROXURIDINE; CYCLIC AMP; OCTREOTIDE; PASIREOTIDE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C INHIBITOR; PROSTAGLANDIN E2; SOMATOSTATIN;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NICK END LABELING; PLACENTA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TISSUE DISTRIBUTION; TROPHOBLAST;

CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP; FEMALE; HUMANS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; TROPHOBLASTS;

EID: 49049109229     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.05.009     Document Type: Article

References (38)

1. Patel Y.C. Somatostatin and its receptor family. Front Neuroendocrinol 20 (1999) 157-198
2. Kumasaka T., Nishi N., Yaoi Y., Saito M., Okayasu I., Shimizu K., et al. Demonstration of immunoreactive somatostatin-like substance in villi and decidua in early pregnancy. Am J Obstet Gynecol 134 (1979) 39-44
3. Watkins W.B., and Yen S.S. Somatostatin in cytotrophoblast of the immature human placenta: localization by immunoperoxidase cytochemistry. J Clin Endocrinol Metab 50 (1980) 969-971
4. Caron P., Buscail L., Beckers A., Esteve J.P., Igout A., Hennen G., et al. Expression of somatostatin receptor sst4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. J Clin Endocrinol Metab 82 (1997) 3771-3776
5. Tsalikian E., Foley T.P., and Becker D.J. Characterization of somatostatin specific binding in plasma cell membranes of human placenta. Pediatr Res 18 (1984) 953-957
6. Grullon K., Jacobs M.M., Li S.X., and Illsley N.P. Beta-adrenergic regulation of cyclic AMP synthesis in cultured human syncytiotrophoblast. Placenta 16 (1995) 589-597
7. Pola S., Cattaneo M.G., and Vicentini L.M. Anti-migratory and anti-invasive effect of somatostatin in human neuroblastoma cells: involvement of Rac and MAP kinase activity. J Biol Chem 278 (2003) 40601-40606
8. Lunghi L., Ferretti M.E., Medici S., Biondi C., and Vesce F. Control of human trophoblast function. Reprod Biol Endocrinol 5 (2007) 6-19
9. Vanetti M., Vogt G., and Hollt V. The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization. FEBS Lett 33 (1993) 260-266
10. Schulz S., Schulz S., Schmitt J., Wiborny D., Schmidt H., Olbricht S., et al. Immunohistochemical detection of somatostatin receptors sst1, sst2A, sst2B, and sst3 in paraffin-embedded breast cancer tissue using subtype-specific antibodies. Clin Cancer Res 4 (1998) 2047-2052
11. Abelli L., Gallo V.P., Civinini A., and Mastrolia L. Immunohistochemical and ultrastructural evidence of adrenal chromaffin cell subtypes in sea bass Dicentrarchus labrax (L.). Gen Comp Endocrinol 102 (1996) 113-122
12. 2 inhibits proliferation and migration of HTR-8/SVneo cells, a human trophoblast-derived cell line. Placenta 27 (2006) 592-601
13. Lambooij A.C., Kuijpers R.W., van Lichtenauer-Kaligis E.G., Kliffen M., Baarsma G.S., van Hagen P.M., et al. Somatostatin receptor 2A expression in choroidal neovascularization secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci 41 (2000) 2329-2335
14. Selvey S., Thompson E.W., Matthaei K., Lea R.A., Irving M.G., and Griffiths L.R. B-Actin - an unsuitable internal control for RT-PCR. Mol Cell Probes 15 (2001) 307-311
15. Brown B.L., Ekins R.P., and Albano J.D. Saturation assay for cyclic AMP using endogenous binding protein. Adv Cyclic Nucleotide Res 2 (1972) 25-40
16. Fiorini S., Ferretti M.E., Biondi C., Pavan B., Lunghi L., Paganetto G., et al. 17β-estradiol stimulates arachidonate release from amnion-like WISH cells through a rapid mechanism involving a membrane receptor. Endocrinology 144 (2003) 3359-3367
17. Schmid H.A., and Silva A.P. Short- and long-term effects of octreotide and SOM230 on GH, IGF-I, ACTH, corticosterone and ghrelin in rats. J Endocrinol Invest 28 (2005) 28-35
18. Nunn C., Schoeffter P., Langenegger D., and Hoyer D. Functional characterization of the putative somatostatin sst2 receptor antagonist CYN 154806. Naunyn Schmiedebergs Arch Pharmacol 367 (2003) 1-9
19. Hoyer D., Nunn C., Hannon J., Schoeffter P., Feuerbach D., Schuepbach E., et al. SRA880, in vitro characterization of the first non-peptide somatostatin sst(1) receptor antagonist. Neurosci Lett 361 (2004) 132-135
20. Hoyer D., Vassout A., Gentsch C., Enz A., Vigouret J.M., Jaton A., et al. Functional characterization of NVP ACQ090, a somatostatin sst3 receptor antagonist. Soc Neuroscience Abs (2004)
21. You J., Marrelli S.P., and Bryan Jr. R.M. Role of cytoplasmic phospholipase A2 in endothelium-derived hyperpolarizing factor dilations of rat middle cerebral arteries. J Cereb Blood Flow Metab 22 (2002) 1239-1247
22. Wright J.K., Dunk C.E., Perkins J.E., Winterhager E., Kingdom J.C., and Lye S.L. EGF modulates trophoblast migration through regulation of Connexin 40. Placenta 27 Suppl A (2006) S114-S121
23. Bito H., Mori M., Sakanaka C., Takano T., Honda Z., Gotoh Y., et al. Functional coupling of SSTR4, a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonate release and activation of the mitogen-activated protein kinase cascade. J Biol Chem 269 (1994) 12722-12730
24. Alderton F., Fan T.P., and Humphrey P.P. Somatostatin receptor-mediated arachidonic acid mobilization: evidence for partial agonism of synthetic peptides. Br J Pharmacol 132 (2001) 760-766
25. Cervia D., Fiorini S., Pavan B., Biondi C., and Bagnoli P. Somatostatin (SRIF) modulates distinct signaling pathways in rat pituitary tumor cells; negative coupling of SRIF receptor subtypes 1 and 2 to arachidonic acid release. Naunyn Schmiedebergs Arch Pharmacol 365 (2002) 200-209
26. Masmoudi O., Gandolfo P., Tokay T., Leprince J., Ravni A., Vaudry H., et al. Somatostatin down-regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes. J Neurochem 94 (2005) 561-571
27. Engstrom M., Savola J.M., and Wurster S. Differential efficacies of somatostatin receptor agonists for G-protein activation and desensitization of somatostatin receptor subtype 4-mediated responses. J Pharmacol Exp Ther 316 (2006) 1262-1268
28. Hipkin R.W., Friedman J., Clark R.B., Eppler C.M., and Schounbrunn A. Agonist-induced desensitization, internalization, and phosphorylation of the sst2A somatostatin receptor. J Biol Chem 272 (1997) 13869-13876
29. Schindler M., Kidd E.J., Carruthers A.M., Wyatt M.A., Jarvie E.M., Sellers L.A., et al. Molecular cloning and functional characterization of a rat somatostatin sst2(b) receptor splice variant. Br J Pharmacol 125 (1998) 209-217
30. Graham C.H., Hawley T.S., Hawley R.G., MacDougall J.R., Kerbel R.S., Khoo N., et al. Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res 206 (1993) 204-211
31. Sawai K., Azuma C., Koyama M., Hashimoto K., Kimura T., Samejima Y., et al. The novel role of 3′,5′-guanosine monophosphate (cGMP) on the differentiation of trophoblasts: comparison with the effects of 3′,5′-adenosine monophosphate (cAMP). Early Pregnancy 2 (1996) 244-252
32. Zygmunt M., Hahn D., Munstedt K., Bischof P., and Lang U. Invasion of cytotrophoblastic JEG-3 cells is stimulated by hCG in vitro. Placenta 19 (1998) 587-593
33. McKinnon T., Chakraborty C., Gleeson L.M., Chidiac P., and Lala P.K. Stimulation of human extravillous trophoblast migration by IGF-II is mediated by IGF type 2 receptor involving inhibitory G protein(s) and phosphorylation of MAPK. J Clin Endocrinol Metab 86 (2001) 3665-3674
34. Nie D., Che M., Grignon D., Tang K., and Honn K.W. Role of eicosanoids in prostate cancer progression. Cancer Metastasis Rev 20 (2001) 195-206
35. Hammamieh R., Sumaida D., Zhang X., Das R., and Jett M. Control of the growth of human breast cancer cells in culture by manipulation of arachidonate metabolism. BMC Cancer 7 (2007) 138-146
36. Koper J.W., Markstein R., Kohler C., Kwekkeboom D.J., Avezaat C.J., Lamberts S.W., et al. Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth. J Clin Endocrinol Metab 74 (1992) 543-547
37. Sgambati S.A., Zarif A., and Basson M.D. Octreotide differentially modulates human Caco-2 intestinal epithelial cell proliferation and differentiation by decreasing intracellular cAMP. Regul Pept 61 (1996) 219-227
38. Oomen S.P., van Hennik P.B., Antonissen C., Lichtenauer-Kaligis E.G., Hofland L.J., Lamberts S.W., et al. Somatostatin is a selective chemoattractant for primitive (CD34(+)) hematopoietic progenitor cells. Exp Hematol 30 (2002) 116-125